Veterinary Eye Care Market Size To Reach $8.69 Billion By 2033

Veterinary Eye Care Market Growth & Trends

The global veterinary eye care market size is expected to reach USD 8.69 billion by 2033, registering a CAGR of 6.37% from 2025 to 2033, according to a new report by Grand View Research, Inc. Rising prevalence of ocular diseases supported by advancement in diagnostic & treatment technologies are key growth drivers for this market. Moreover, rising pet population, increasing insurance coverage, and supportive government regulations are anticipated to boost market growth. Veterinarians are currently capable to diagnose and treat ocular diseases in animals with improved precision and efficacy due to technological developments in the field. The introduction of optical coherence tomography (OCT), a non-invasive imaging technique that offers high-resolution, cross-sectional images of ocular tissues, is one instance of such advancements.

Veterinarians can see remarkably detailed images of the layers of the retina, optic nerve, and other ocular structures due to OCT. When it comes to diagnosing diseases like macular edema, retinal degeneration, and abnormalities of the optic nerve in animals, this technology is especially helpful. A further instance involves electroretinography (ERG), a diagnostic technique that assesses how well the retina functions in response to light stimulation. ERG provides important information about retinal function and health by measuring the electrical activity of retinal cells. ERG is used by veterinarians to diagnose diseases like hereditary retinal disorders, retinal degeneration, and retinal toxicity brought on by drugs or environmental exposure. Veterinarians can precisely diagnose and track the development of these conditions by evaluating the electrical responses of the retina. This enables them to make apprised treatment decisions and provide the most effective treatment.

Technological developments have resulted in novel treatment approaches for ocular diseases in animals in addition to diagnostic tools. For instance, laser therapy is gaining popularity as a treatment for several eye disorders, such as corneal ulcers, retinal detachment, and glaucoma. With laser therapy, damaged tissues can be precisely and specifically treated, reducing collateral damage to surrounding structures and accelerating the healing process. Furthermore, improvements in surgical methods, like microsurgery and minimally invasive procedures, have decreased postoperative complications and enhanced surgical results in animals undergoing ophthalmic surgery. In broad terms, the ability of veterinarians to detect, treat, and manage ocular diseases in animals has been improved by technological innovations like OCT, ERG, laser therapy, and complex surgical techniques.

To further develop the industry and meet the needs of animals with ocular conditions, market participants are taking an active role in a variety of initiatives. To increase the efficacy and efficiency of ophthalmic treatments, these activities include the development and acquisition of innovative products and technologies, such as patented crosslinked hyaluronic acid technology. Furthermore, targeted DNA tests for the early detection and prevention of inherited eye diseases in particular breeds are being developed as a result of cooperative efforts between academic institutions, veterinary professionals, and research organizations to identify genetic variations responsible for these conditions. The advancement of veterinary eye care and the enhancement of animal ocular health outcomes the combined impact of these initiatives.

For example, SentrX Animal Care, using its proprietary BioHance technology, was taken over by Domes Pharma in August 2023. Through fewer applications, BioHance, a patented crosslinked Hyaluronic Acid technology, improves and speeds up the body's natural healing, hydration, and lubricating processes. Aiming to eliminate an eye disease that affects Old English Sheepdogs, the University of Cambridge, Veterinary Vision, and the Cambridgeshire Animal Hospital are working together to achieve this goal. Scientists studying genetics and veterinary medicine have discovered the genetic variation responsible for this breed's inherited eye disease syndrome. Dog breeders can use the test that has been developed to check whether their dogs carry the mutation.

 Request a free sample copy or view report summary: Veterinary Eye Care Market Report

Veterinary Eye Care Market Report Highlights

• In 2024, the canine segment accounted for the largest share of 33.83%. Feline is emerging as the fastest-growing category in the market.

• Devices and instruments represented the largest share of about 61% in 2024. The medications segment is the fastest-growing over the forecast period.

• Uveitis represented the largest segment in 2024. Conjunctivitis is emerging as the fastest-growing segment in the market, fueled by its widespread occurrence in dogs and cats.

• Veterinary hospitals and clinics account for the largest market share, as they serve as primary centers for diagnosis, treatment, and management of ocular disorders in animals. E-commerce is the fastest-growing segment in the market.

• The North American veterinary eye care market had a share of about 40% in 2024. The veterinary eye care market in the Asia Pacific is the fastest-growing region over the forecast period.

Veterinary Eye Care Market Segmentation

Grand View Research has segmented the global veterinary eye care market report based on animal, product, indication, distribution channel, and region:

Animal Outlook (Revenue, USD Million, 2021 - 2033)

• Canine

• Feline

• Equine

• Bovine

• Others

Product Outlook (Revenue, USD Million, 2021 - 2033)

• Devices & Instruments

  • Diagnostic Devices

    • Tonometers

    • Ophthalmic Test Kits

    • Electroretinogram (ERG)

    • Fundus Camera

    • Ophthalmoscopes

    • Pachymeter

    • Other Diagnostic Devices

  • Treatment Devices

    • Lenses

      • Bandage Lenses

      • Intraocular Lenses

    • Laser Devices

    • Other Treatment Devices

• Medications

  • Antibiotics

  • NSAIDs

  • Corticosteroids

  • Lubricants / Artificial Tears

  • Analgesics / Pain Relievers

  • Other Medications

Indication Outlook (Revenue, USD Million, 2021 - 2033)

• Eyelid Abnormalities

• Cataract

• Glaucoma

• Retinal Complications

• Uveitis

• Conjunctivitis

• Corneal Complications

• Other Indications

Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)

• Veterinary Hospitals & Clinics

• Specialty Stores

• E-Commerce

• Other Distribution Channels

Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • India

  • China

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

  • Qatar

  • Oman

List of Key Players in the Veterinary Eye Care Market

• Merck & Co., Inc.

• An-Vision GmbH

• Jorgensen Laboratories

• LKC Technologies Inc.

• Accutome Inc.

• Dechra Pharmaceuticals

• Bausch & Lomb Incorporated

• Zoetis Services LLC.

• Ceva Sante Animale

• Sandoz

• Boehringer Ingelheim

• I-Med Animal Health

• Iridex Corporation

• Baxter (Welch Allyn)

• OptoMed

• Reichert, Inc.

• Occuity